• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Gemina Laboratories Ltd (CSE:GLAB)

0.0600 UNCHANGED
Last Price Updated: 10:42 AM EST, Jan 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Gemina Laboratories Ltd

< Previous 1 2 Next >
News headline image
Gemina Laboratories Announces Private Placement
November 13, 2024
Via ACCESSWIRE
News headline image
Gemina Laboratories Strategic Update
July 10, 2024
Via ACCESSWIRE
News headline image
Life Science Virtual Investor Forum Presentations Now Available for Online Viewing
June 21, 2024
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Gemina Laboratories Commences Trading on the OTCQB Market in the United States
June 20, 2024
Via ACCESSWIRE
News headline image
Life Sciences Virtual Investor Forum Agenda Announced for June 20th
June 18, 2024
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Gemina Labs Announces Addition to its IP Portfolio
April 09, 2024
Via ACCESSWIRE
News headline image
Gemina Labs to Present at the Life Science Investor Forum June 20th
June 17, 2024
Company invites individual and institutional investors, as well as advisors and analysts, to attend in person or online at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Gemina Laboratories Sign First Strategic License Agreement
April 02, 2024
Via ACCESSWIRE
News headline image
Gemina Labs Strategic Update: Focusing on Respiratory Infections and Strategic Partnerships
March 21, 2024
Via ACCESSWIRE
News headline image
Gemina Announces Closing of $910,000 Convertible Note Financing
March 19, 2024
Via ACCESSWIRE
News headline image
Gemina Laboratories to Participate in Poster Session at American Association of Clinical Chemistry Annual Scientific Meeting
June 15, 2023
Via ACCESSWIRE
News headline image
Gemina's Recent Investment into RAPIvD Sees Immediate Progress
December 13, 2022
Via ACCESSWIRE
ReadyGo Diagnostics Initiates An Assay Development Contract With Gemina Laboratories For The Detection Of Dengue From Saliva Samples
October 10, 2023
Via Get News
News headline image
Gemina Laboratories Announces Major Breakthrough in Environmentally Friendly Lateral Flow Test Design by Removing the Requirement for Nitrocellulose
July 25, 2023
Via ACCESSWIRE
News headline image
Gemina Laboratories and ReadyGo Diagnostics Achieve Mycobacterium Tuberculosis Diagnosis in Saliva
June 05, 2023
Via ACCESSWIRE
News headline image
Gemina Labs Antibody Immobilization Chemistry Platform Demonstrates Major Lateral Flow Assay Performance Improvement
May 17, 2023
Via ACCESSWIRE
News headline image
Gemina Laboratories to Host Investor Webinar on March 30, 2023
March 27, 2023
Via ACCESSWIRE
News headline image
Gemina Labs Appoints Diagnostic Strategist Martha Najib to the Board
March 07, 2023
Via ACCESSWIRE
News headline image
Gemina Labs Announces Appointment of Healthcare Industry Leader Dr. Bola Grace to The Board of Directors
January 25, 2023
Via ACCESSWIRE
News headline image
Gemina Labs Appoints Top Ranked UK Analyst and Scientist, Dr. Stefan Hamill as Vice President, Strategy
January 23, 2023
Via ACCESSWIRE
News headline image
Gemina Labs Strategic Update: Respiratory Infections the Immediate Focus and New Strategic Partnerships on the Horizon
January 10, 2023
Via ACCESSWIRE
News headline image
Gemina Labs Completes Influenza A/B Diagnostic Test Prototype
January 06, 2023
Via ACCESSWIRE
News headline image
Gemina Labs Appoints Dr Michael Shannon as Chair of Clinical Advisory Board
December 20, 2022
Via ACCESSWIRE
News headline image
Gemina Labs Announces Research Collaboration on Next Generation Biosensors
December 19, 2022
Via ACCESSWIRE
News headline image
Gemina Labs Announces Strategic Stake in British Rapid Test Optimizer Rapivd Limited
December 07, 2022
Via ACCESSWIRE
News headline image
Gemina Labs Enters into Licence and Manufacturing Agreements
October 06, 2022
Via ACCESSWIRE
News headline image
Gemina Labs Presents at the H.C. Wainwright Global Investment Conference
September 12, 2022
Via ACCESSWIRE
News headline image
Gemina Labs Appoints Diagnostic Executive Brian Firth as Chief Executive Officer
September 06, 2022
Via ACCESSWIRE
News headline image
Gemina Labs Announces Closing Of Concurrent Private Placement
July 11, 2022
VANCOUVER, BC / ACCESSWIRE / July 11, 2022 / Gemina Laboratories Ltd. (CSE:GLAB)(FRA:8I7) (the "Company" or "Gemina") is pleased to announce the closing of its previously announced non-brokered private... 
From Gemina Laboratories Ltd.
Via AccessWire
News headline image
Gemina Announces Closing Of Prospectus Supplement Offering And Update To Concurrent Non-brokered Private Placement
June 30, 2022
VANCOUVER, BC / ACCESSWIRE / June 30, 2022 / Gemina Laboratories Ltd. (the "Company" or "Gemina") (CSE:GLAB)(FRA:8I7) is pleased to announce that the Company has closed its previously announced... 
From Gemina Laboratories Ltd.
Via AccessWire
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap